What we do
Platform
We are building a platform to identify target biomarkers and develop new digital therapeutics to treat or manage various neurological disorders.
Convergence
We take pride in our in-house convergence medical and tech professionals comprised of neurologists, software and game/VR developers, engineers, AI scientists, perceptual psychologists, and mathematicians. It enables us bring neuroscience, medicine and IT together to change how medicine is designed and delivered.
We plan to develop pipelines for various brain disorders to become a leading digital therapeutics platform company in the future.
Evidence
We have initiated a pivotal clinical trial of our first product, Nunap Vision, which provides visual perceptual training to treat visual field defects caused by brain damage. It is the first digital therapeutics clinical trial approved by MFDS (formerly known as KFDA) in South Korea.
Nunap Vision is a SaMD (Software as a Medical Device) utilizing HMD VR. While its clinical efficacy has already been demonstrated in previous proof-of-concept studies, we designed the pivotal clinical trial to be multi-center, double-blind, randomized, and placebo-controlled for further validation.
Nunapsians
Kang, Dong Wha
Chief Executive Officer
Cho, Kyu Sok
Chief Financial Officer
Hah, Tae Hwan
Chief Technology Officer
Lee, Jee Hyun
VP of People and Culture
Kim, Yong Hwan
Head of Research
Cho, Moonju
Head of Clinical Trial Management
Lee, Yuju
Senior UX/UI Designer
Jang, Soongi
Senior QA/RA Manager
Ryu, Yong Hoe
Software Engineer
Hong, Rak Kyeun
Neuroscience Researcher
Cho, Ju Mi
Financial Manager
Lee, Hyun Seok
Neuroscience Researcher
Whang, Soo young
Neuroscience Researcher
Kim, Eun Ji
Clinical Research Coordinator
Choi, Yeseul
Neuroscience Researcher
Noh, Su Mi
QA/RA Manager
Kim, Ji Hyun
IT Planner
Kim, Ji Yeong
Clinical Research Coordinator
Kim, Yu Jin
Neuroscience Researcher
Contact Us
E-mail.
Tel. + 82 2 488 6542
Fax. + 82 2 488 6541
Address.
11F Asan Institute for Life Sciences, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea